Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

KOSDAQ/226950 stock hub

KOSDAQ/226950 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KOSDAQ/226950is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.4T

KOSDAQ

Market data

Live price

Current market quote for this ticker.

Current price

KOSDAQ/226950

In the news

Latest news · KOSDAQ/226950

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/En/a

P25 12P50 23.1P75 39.5

ROE-18.7

P25 -17.1P50 0.7P75 8.5

ROIC-16.2

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KOSDAQ/226950 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

177

Groups with data

Currency

KRW

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Enterprise value	KRW 3.3T
Exchange	KOSDAQ
Financial currency	KRW
First seen	2026-05-10
Industry	Biotechnology
Isin	KR7226950004
Last refreshed	2026-05-10
Market cap	KRW 3.4T
Price	KRW 168,000
Price currency	KRW
Sector	Healthcare
Sic	2836
Symbol	kosdaq/226950
Website	https://www.olixpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.46%
EV Earnings	-209.81x
EV/FCF	-192.46x
EV/Sales	225.2x
FCF yield	-0.5%
P/B ratio	22.72x
P/S ratio	232.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-204.35%
EBITDA Margin	-187.63%
Gross margin	97.73%
Gross Profit	KRW 14.3B
Gross Profit Growth	164.05%
Gross Profit Growth3 Y	16.3%
Gross Profit Growth5 Y	42.78%
Net Income	KRW -15.7B
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Pretax Margin	-90.35%
Profit Margin	-107.33%
ROA	-14.05
Roa5y	-15.4
ROCE	-17.22
ROE	-18.68
Roe5y	-65.08
ROIC	-16.22

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	251.77%
Cagr3y	99.34%
Cagr5y	32.92%
EPS Growth Quarters	3
EPS Growth Years	1
Revenue Growth	158.35x
Revenue Growth Q	9,920.28x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	16.31x
Revenue Growth5 Y	42.75x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.11
Assets	KRW 195.4B
Cash	KRW 132.5B
Current Assets	KRW 140.9B
Current Liabilities	KRW 21.3B
Debt	KRW 23.3B
Debt Equity	KRW 0.16
Debt FCF	KRW -1.36
Equity	KRW 150.1B
Interest Coverage	-16.47
Liabilities	KRW 45.3B
Long Term Assets	KRW 54.5B
Long Term Liabilities	KRW 24B
Net Cash	KRW 109.2B
Net Cash By Market Cap	KRW 3.2
Net Debt Equity	KRW -0.73
Tangible Book Value	KRW 146.4B
Tangible Book Value Per Share	KRW 7,253
WACC	6.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.6
Inventory Turnover	0.7
Net Working Capital	KRW -8.5B
Quick ratio	6.51
Working Capital	KRW 119.5B
Working Capital Turnover	KRW 0.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-16.77%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	251.46%
200-day SMA	122,328.5
3Y total return	692.45%
50-day SMA	178,492
50-day SMA vs 200-day SMA	50over200
5Y total return	314.82%
All Time High	217,000
All Time High Change	-22.58%
All Time High Date	2026-03-06
All Time Low	8,280
All Time Low Change	1,928.99%
All Time Low Date	2024-06-24
ATR	13,717.3
Beta	0.38
Beta1y	-0.01
Beta2y	-0.39
Ch YTD	19.66
High	178,400
High52	217,000
High52 Date	2026-03-06
High52ch	-22.58%
Low	165,800
Low52	34,500
Low52 Date	2025-06-30
Low52ch	386.96%
Ma50ch	-5.88%
Price vs 200-day SMA	37.34%
RSI	46.71
RSI Monthly	75.68
RSI Weekly	56.13
Sharpe ratio	1.7x
Sortino ratio	3
Total Return	-16.77%
Tr YTD	19.66
Tr1m	7.35%
Tr1w	-3.56%
Tr3m	37.26%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -30B
Operating margin	-204.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	16,809,325%
Net Borrowing	1,865,546,350
Shares Insiders	17.2%
Shares Institutions	20.84%
Shares Out	20,300,583
Shares Qo Q	0.71%
Shares Yo Y	16.77%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -19.9B
Average Volume	268,032.4x
Bv Per Share	7,349.7
CAPEX	KRW -1.3B
Ch1m	7.35
Ch1w	-3.56
Ch1y	251.5
Ch3m	37.26
Ch3y	692.5
Ch5y	314.8
Ch6m	38.84
Change	0.24%
Change From Open	-2.33
Close	167,600
Days Gap	2.63
Depreciation Amortization	2,453,631,780
Dollar Volume	41,040,720,000
Earnings Date	2026-03-27
EBIT	KRW -30B
EBITDA	KRW -27.5B
EPS	KRW -800
F Score	4
FCF	KRW -17.2B
FCF EV Yield	-0.52x
FCF Per Share	KRW -845
Financing CF	123,839,317,290
Fiscal Year End	December
Founded	2,010
Income Tax	KRW 2.5B
Investing CF	-104,942,356,090
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2025-12-31
Last Split Date	2020-12-03
Last Split Type	Forward
Ma150	142,714.7
Ma150ch	17.72%
Ma20	172,090
Ma20ch	-2.38%
Net CF	2,475,204,390
Open	172,000
Position In Range	17.46
Ppne	50,498,513,020
Price Date	2026-05-08
Ptbv Ratio	23.29
Relative Volume	0.93x
Revenue	14,666,854,270x
SBC By Revenue	18.93x
Share Based Comp	2,776,802,860
Tax By Revenue	16.98x
Tr6m	38.84%
Volume	244,290
Z Score	16.08

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KOSDAQ/226950 pay a dividend?

Capital-return profile for this ticker.

Performance

KOSDAQ/226950 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KOSDAQ/226950?

Insider, institutional, and short-interest positioning.

Institutional ownership

+20.8%

Share of float held by funds and institutions

Insider ownership

+17.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+16.8%

Negative means the company is buying back shares.

Technical

KOSDAQ/226950 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.7

Neutral momentum band

Price vs 200-day MA

+37.3%

50/200-day relationship not available

Beta (5Y)

0.38

Less volatile than the market

Sharpe ratio

1.70

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KOSDAQ/226950

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/226950 stock rating?

kosdaq/226950 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/226950 analysis?

The full report lives at /stocks/kosdaq/226950/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/226950?

The latest report frames kosdaq/226950 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/226950 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.